Establishment and validation of a risk prediction model for high-grade cervical lesions

Eur J Obstet Gynecol Reprod Biol. 2023 Feb:281:1-6. doi: 10.1016/j.ejogrb.2022.12.005. Epub 2022 Dec 6.

Abstract

Objective: To establish and validate a risk prediction model for cervical high-grade squamous intraepithelial lesions (HSIL).

Methods: This retrospective study included patients who underwent cervical biopsies at the Cervical Disease Centre of Maternal and Child Hospital of Hubei Province between January 2021 and December 2021.

Results: A total of 1630 patients were divided into the HSIL + cervical lesion group (n = 186) and the ≤ LSIL cervical lesions group (n = 1444). LSIL, ASC-H, HSIL and SCC, high-risk HPV, HPV16, HPV18/45, multiple HPV strains, acetowhite epithelium, atypical vessels, and mosaicity were independently associated with HSIL + lesions. These factors were used to establish a risk prediction model with a demonstrated area under the curve (AUC) of 0.851 and a C-index of 0.829. Calibration curve analysis showed that the model performed well, with a mean absolute error (MAE) of 0.005. The decision curve showed that the model created by combining the risk factors was more specific and sensitive than each predictive variable.

Conclusion: The model for predicting HSIL demonstrated promising predictive capability and might help identify patients requiring biopsy and treatment.

Keywords: Atypical squamous cells of the cervix; Biopsy; Cervical intraepithelial neoplasia; Early detection of cancer; Papillomavirus infection; Uterine cervical neoplasms.

MeSH terms

  • Child
  • Female
  • Humans
  • Papillomaviridae
  • Papillomavirus Infections*
  • Retrospective Studies
  • Uterine Cervical Dysplasia* / pathology
  • Uterine Cervical Neoplasms* / pathology
  • Vaginal Smears